The role of renal replacement therapy quantification in acute renal failure

W. R. Clark, B. A. Mueller, M. A. Kraus, W. L. Macias

Research output: Contribution to journalArticle

8 Scopus citations


The recognition that both morbidity and mortality are inversely related to delivered hemodialysis (HD) dose in end-stage renal disease (ESRD) patients has substantially changed clinical practices in the United States. A number of quantification techniques, which differ greatly in complexity and sophistication, are now used in ESRD patients. Investigators recently have attempted to extrapolate some of these ESRD quantification methods to the acute renal failure (ARF) setting. This review focuses on these recent attempts. Both patient-related and renal replacement therapy (RRT)-related differences in ESRD and ARF are discussed. In addition, the potential pitfalls of extrapolating certain ESRD quantification methods to RRT in ARF are discussed. Prescription considerations for both intermittent HD (IHD) and continuous RRT (CRRT) are presented. The optimal technique for RRT quantification in ARF remains to be determined.

Original languageEnglish (US)
Pages (from-to)S10-S14
JournalAmerican Journal of Kidney Diseases
Issue number5 SUPPL.
StatePublished - Jan 1 1997


  • Acute renal failure
  • Azotemia
  • Hemodialysis
  • Hemofiltration
  • Prescription

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'The role of renal replacement therapy quantification in acute renal failure'. Together they form a unique fingerprint.

  • Cite this